Ranbaxy Seeks to Sell India-Made Generics in Japan

Nov 19, 2013


Ranbaxy Laboratories, India's first multinational pharmaceutical company, plans to supply medicines to Japan from its Indian facilities, according to sources.

Ranbaxy is yet to get approvals from the Japanese regulatory agency, but is reportedly in advanced talks with Japan's Ministry of Health, Labour and Welfare.

In 2008, Japan's No. 3 drugmaker, Daiichi Sankyo, bought 63.9 percent of Ranbaxy for $4.2 billion from the controlling shareholder group. Daiichi Sankyo Espha Co Ltd will be the vehicle to introduce generic products in Japan, through a joint team set up for development, sales and distribution.

Read the full article here

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments